BAXTER INTERNATIONAL INC

BAX NYSE CIK: 0000010456

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address ONE BAXTER PARKWAY, DEERFIELD, IL, 60015
Mailing Address ONE BAXTER PARKWAY, DEERFIELD, IL, 60015
Phone 2249482000
Fiscal Year End 1231
EIN 360781620

Financial Overview

FY2025

$2.66B
Net Income
$5.25
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 12, 2026 View on SEC
10-K Annual financial report February 12, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 5, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 21, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 21, 2026 View on SEC
8-K Current report of material events December 22, 2025 View on SEC

Annual Reports

10-K February 12, 2026
  • Successful sale of BioPharma Solutions business for approximately $4.25 billion, generating substantial capital.
  • Planned spin-off of Kidney Care business into a new publicly traded company, Vantive, by early 2025.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.